Biomea Fusion (BMEA) Stock Forecast & Price Target $0.77 -0.07 (-7.84%) As of 02:27 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest Biomea Fusion - Analysts' Recommendations and Stock Price Forecast (2026) How MarketBeat Calculates Price Target and Consensus Rating Consensus Rating Moderate BuyBased on 7 Analyst RatingsSell1Hold0Buy6 Based on 7 Wall Street analysts who have issued ratings for Biomea Fusion in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 7 analysts, 1 has given a sell rating, and 6 have given a buy rating for BMEA. Consensus Price Target $7.60887.01% Upside According to the 7 analysts' twelve-month price targets for Biomea Fusion, the average price target is $7.60. The highest price target for BMEA is $12.00, while the lowest price target for BMEA is $4.00. The average price target represents a forecasted upside of 887.01% from the current price of $0.77. MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Get the Latest News and Ratings for BMEA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Biomea Fusion and its competitors. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BMEA Analyst Ratings Over TimeTypeCurrent Forecast10/20/25 to 10/20/261 Month Ago9/20/25 to 9/20/263 Months Ago7/22/25 to 7/22/261 Year Ago10/20/24 to 10/20/25Strong Buy0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)1 Strong Buy rating(s)Buy6 Buy rating(s)5 Buy rating(s)7 Buy rating(s)6 Buy rating(s)Hold0 Hold rating(s)0 Hold rating(s)0 Hold rating(s)1 Hold rating(s)Sell1 Sell rating(s)1 Sell rating(s)1 Sell rating(s)1 Sell rating(s)Consensus Price Target$7.60$9.00$8.50$9.50Forecasted Upside887.01% Upside391.80% Upside558.91% Upside493.75% UpsideConsensus RatingModerate BuyModerate BuyModerate BuyModerate Buy BMEA Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History BMEA Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table Biomea Fusion Stock vs. The CompetitionTypeBiomea FusionHealthcare CompaniesBroader MarketConsensus Rating Score 2.71 2.32 2.53Consensus RatingModerate BuyHoldModerate BuyPredicted Upside887.01% Upside1,424.06% Upside17.24% UpsideNews Sentiment RatingNeutral NewsSee Recent BMEA NewsNeutral NewsPositive News Recent Analyst Forecasts and Stock Ratings Most Recent from Each Brokerage All Show All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action 10/20/2024 - 10/20/2026 Report Date Report Date From Report Date To 1M3M6MYTD1Y2Y3Y5Y More filters Fewer filters Done 0 Results Export DateBrokerageAnalystActionRatingPrice TargetReport Date Upside/DownsideDetails10/14/2026 Citizens Jmp4 of 5 starsJonathan Wolleben5 of 5 starsReiterated RatingMarket Outperform$7.00+455.55%10/14/2026 HC Wainwright4 of 5 starsJoseph Pantginis4 of 5 starsReiterated RatingBuy$4.00+217.46%10/7/2026 Brookline Capital MarketsNot RatedKumaraguru RajaNot RatedInitiated CoverageBuy9/30/2026 CitigroupSubscribe to MarketBeat All Access to unlock brokerage rankings Reiterated RatingMarket Outperform9/28/2026 Weiss RatingsSubscribe to MarketBeat All Access to unlock brokerage rankings Reiterated RatingSell (E+)4/28/2026 D. Boral CapitalSubscribe to MarketBeat All Access to unlock brokerage rankingsJason KolbertSubscribe to MarketBeat All Access to unlock analyst rankingsReiterated RatingBuy$12.00+625.07%1/13/2026 Rodman & RenshawSubscribe to MarketBeat All Access to unlock brokerage rankings Initiated CoverageBuy$8.00+446.07%8/28/2025 Jefferies Financial GroupSubscribe to MarketBeat All Access to unlock brokerage rankingsRoger SongSubscribe to MarketBeat All Access to unlock analyst rankingsInitiated CoverageBuy$5.00+168.82%8/6/2025 ScotiabankSubscribe to MarketBeat All Access to unlock brokerage rankingsGeorge FarmerSubscribe to MarketBeat All Access to unlock analyst rankingsLower TargetSector Outperform$30.00 ➝ $10.00+555.73%8/5/2025 OppenheimerSubscribe to MarketBeat All Access to unlock brokerage rankings Reiterated RatingOutperform$40,000,000,000,000 (Ad)The national debt just hit 40 trillion dollars, and the U.S. now spends more on interest payments than on its entire military budget. Central banks have bought over 1,000 tonnes of gold a year for three years running, trading paper for metal.See what the money printers see - download the free 2026 Wealth Protection Guide6/3/2025 Piper SandlerSubscribe to MarketBeat All Access to unlock brokerage rankingsEdward TenthoffSubscribe to MarketBeat All Access to unlock analyst rankingsInitiated CoverageOverweight$7.00+351.61%4/2/2025 BarclaysSubscribe to MarketBeat All Access to unlock brokerage rankingsPeter LawsonSubscribe to MarketBeat All Access to unlock analyst rankingsLower TargetEqual Weight$11.00 ➝ $3.00+46.70%Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 02:28 PM ET. BMEA Forecast - Frequently Asked Questions What is Biomea Fusion's forecast for 2026? According to the research reports of 7 Wall Street equities research analysts, the average twelve-month stock price forecast for Biomea Fusion is $7.60, with a high forecast of $12.00 and a low forecast of $4.00. Should I buy or sell Biomea Fusion stock right now? 7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Biomea Fusion in the last twelve months. There is currently 1 sell rating and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" BMEA shares. Does Biomea Fusion's stock price have much upside? According to analysts, Biomea Fusion's stock has a predicted upside of 887.01% based on their 12-month stock forecasts. What analysts cover Biomea Fusion? Biomea Fusion has been rated by research analysts at Brookline Capital Markets, Citigroup, Citizens Jmp, HC Wainwright, and Weiss Ratings in the past 90 days. Do Wall Street analysts like Biomea Fusion more than its competitors? Analysts like Biomea Fusion more than other "healthcare" companies. The consensus rating for Biomea Fusion is Moderate Buy while the average consensus rating for "healthcare" companies is Hold. Learn more on how BMEA compares to other companies. Stock Forecasts and Research Tools Related Companies EIKN Stock Forecast KYTX Stock Forecast ARCT Stock Forecast CCCC Stock Forecast IRD Stock Forecast ZURA Stock Forecast EBS Stock Forecast AGEN Stock Forecast SRZN Stock Forecast ARTV Stock Forecast Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Brokerages With Biomea Fusion RecommendationsHC WainwrightCitizens JmpBrookline Capital MarketsWall Street ZenCitigroupWeiss RatingsD. Boral CapitalRodman & Renshaw MarketBeat monitors more than a dozen sources for Biomea Fusion analyst ratings, with the most recent rating issued on 10/14/2026. From Our PartnersTrump’s Plan To Cheat HistoryChina has slashed its U.S. Treasury holdings by more than 45% from their peak, while building gold vaults and ...Porter & Company | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | Sponsored$40,000,000,000,000The national debt just hit 40 trillion dollars, and the U.S. now spends more on interest payments than on its ...American Alternative | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | SponsoredINSANE DRONE FOOTAGENew drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and ...Paradigm Press | SponsoredYour book is insideBlane Markham and the Markham Trading Team are giving readers a limited window to download their options strat...TradeWins | SponsoredWhy Some AI Stocks Already Surged Over 300 PercentJason Bodner's system flagged Nvidia before a 7000 percent run, Super Micro Computer before a 2600 percent run...Brownstone Research | SponsoredThe AI Infrastructure Rush Is ON — Watch VDTAVertical Data Inc. (OTCQB: VDTA) is building the infrastructure layer behind the AI boom, from GPU hardware an...Trading Wire | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biomea Fusion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biomea Fusion With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
